Reliance Global Group, Inc.

Greetings and welcome to the Reliance Global Group 2026 first quarter business update call. At this time, all participants are placed on a listen-only mode and a question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. And please note, this conference call is being recorded. I will now turn the conference over to your host, Mr. Ted Avis, Investor Relations. Sir, the floor is yours.

Thanks, Ali. Good afternoon and thank you for joining Reliance Global Group's 2026 First Quarter Financial Results and Business Update Conference Call. On the call with us today are Ezra Bayman, Chairman and Chief Executive Officer of Reliance Global Group, Joel Markovits, Chief Financial Officer of Reliance, and Moish Fishman, Senior Vice President of Strategic Ventures for Reliance. Earlier today, the company announced its operating results for the quarter ended March 31, 2026, and the press release is posted on the company's website, www.relianceglobalgroup.com. In addition, the company will be filing its quarterly report on Form 10Q with the U.S. Securities and Exchange Commission today, which can also be accessed on the company's website as well as the SEC's website at www.sec.gov. If you have any questions after the call or would like any additional information about the company, please contact Crescendo Communications at 212-671-1020. Before Mr. Bayman reviews the company's operating results for the quarter ended March 31, 2026, we would like to remind everyone that this conference call may contain forward-looking statements. All statements other than statements of historical facts contained in the conference call, including statements regarding our future results of operations and financial position, strategy and plans, and our expectations for future operations are forward-looking statements. The words anticipate, estimate, expect, project, plan, seek, intend, believe, may, might, will, should, could, likely, continue, design, and the negative of such terms and other words in terms of similar expressions are intended to identify forward-looking statements. These forward-looking statements are based largely on the company's current expectations and projections about future events and trends that it believes may affect its financial condition, result of operations, strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to several risks, uncertainties, and assumptions, as described in the company's Form 10-K filed with the U.S. Securities and Exchange Commission. Because of these risks, uncertainties, and assumptions, the forward-looking events and circumstances discussed in the conference call may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although the company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, level of activity, performance, or achievements. In addition, neither the company nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. The company disclaims any duty to update any of these forward-looking statements. All forward-looking statements attributable to the company are expressly qualified in their entirety by these cautionary statements, as well as others made on this conference call. You should evaluate all forward-looking statements made by the company in the context of these risks and uncertainties. Having said that, I'd like to turn the call over to Ezra Baiman, Chairman and Chief Executive Officer of Reliance Global Group. Ezra?

Thank you very much, Ted, and good afternoon, everyone. The first quarter represents an important step as we continue executing the strategy we established over the past year. During that time, we focused on simplifying the business, strengthening the balance sheet, and creating a clear framework for long-term growth. We are now building on that foundation and advancing into a more active phase of execution. Our business model is built around two complementary segments. The first is our insurance segment, an insured tech platform, which provides recurring revenue, established carrier and agent relationships, and a scalable distribution infrastructure supported by our technology platforms. This business not only generates consistent operating cash flow, but also provides visibility into market trends, customer behavior, and product demand, all of which support our broader strategic initiatives. The second is our strategic venture segment, which is anchored by Ezra International Group and our Scale 51 model, which together form the foundation of our investment strategy. Ezra International serves as the platform through which we identify and evaluate opportunities across technology and life sciences. While Scale 51 provides the operating discipline we use to deploy capital in stages and scale those businesses over time through an ownership-driven approach. This combination allows us to maintain a stable operating base while selectively allocating capital into opportunities where we identify a high potential for growth and value over time. Within our insurance operations, we continue to operate a more streamlined and efficient business following the portfolio realignment completed in 2025. Those actions reduce complexity, improve cost structure, and position the platform for more scalable growth. ReliExchange remains a central component of this strategy. It provides a technology-enabled distribution network connecting independent agents with carrier markets while allowing us to expand our tech reach without a corresponding increase in fixed costs. During the quarter, we continued to enhance the platform with the rollout of ReliExchange 2.0. which is designed to improve scalability, streamline agent onboarding, and increase overall operating efficiency. These enhancements are intended to support continued growth across the network while improving productivity and reducing friction within the platform. We continue to see a steady engagement in cross-reliance exchange. I believe it positions us well to drive organic growth over time. In addition, 5minuteinsured.com continues to support direct-to-consumer acquisition, complementing our agency network and expanding our distribution capabilities. Taken together, these operations provide a stable foundation that supports both current performance and our broader strategic initiatives. Turning to Ezra International Group and our Scale 51 model, this is where we are beginning to see the strategy translate into execution. Ezra International serves as the platform through which we identify and evaluate opportunities across technology and life sciences, while Scale 51 provides the framework we use to structure investments, deploy capital progressively, and expand our ownership as businesses demonstrate tangible progress. Our focus is on identifying emerging technologies early, deploying capital in a disciplined manner, and increasing ownership of those businesses as those businesses achieve defined technical and commercial milestones. This approach allows us to align capital deployment with performance, manage risk more effectively, and build positions in companies that demonstrate measurable progress. A clear example of the ESJA strategy in action is our investment in Quantum. And Quantum is developing post-Quantum cybersecurity technology designed to address what we believe is a significant long-term challenge in data security. As quantum computing advances, existing encryption methods may become vulnerable, creating the need for a quantum-resistant solution across industries. Through our milestone-based investment structure to date, we have increased our ownership in EnQuantum to approximately 29%, with the increase tied directly to the achievement of defined technical and commercial milestones. This reflects the performance-driven investment model we are applying a core scale 51, where additional capital is committed as execution is demonstrated. We have supercharged the existing top tier in quantum team with commercialization experts that serve to further enhance the reach of the posting quantum cryptography solutions that they provide their customers. More recently, we expanded into a new vertical with the launch of LifeSci Global Group, led by highly qualified biotech professionals, David Turner and Scott Corman. Life sciences represent an area of significant long-term opportunity, particularly as advancements in data, diagnostics, and artificial intelligence continue to reshape how diseases are detected, monitored, and treated. We are seeing increasing demand for early detection, more precise diagnostics, and less invasive testing methods, all of which are driving innovation across the healthcare ecosystem. These trends are creating opportunities for emerging platforms with differentiated technologies to scale over time. LifeSci provides a dedicated platform through which we can pursue these opportunities using the same-stage investment approach, with a focus on expanding our participation in businesses as they progress both technically and commercially. LifeSci Global marked its initial transaction with the completion of a strategic investment into Invernate, I'm sorry, into innovative radiopharmaceuticals. A developer of position imaging, I'm sorry, positron emission tomography imaging and therapeutic radiopharmaceuticals focused initially on neuroblastoma and broader future applications in cardiovascular and neurodegenerative diseases. We also continue to evaluate and support additional opportunities within its expanding pipeline. Opportunities like this align with our focus on emerging technologies that address meaningful clinical needs, particularly in areas where innovation can improve outcomes and expand over time into broader indications. The investment into Innovate reflects the type of differentiated platforms we are targeting within the life sciences sector using our faith capital deployment strategy. In summary, we are building a business with two complementary drivers of value, a stable cash-generating insurance platform and a scalable acquisition plus investment strategy focused on innovation and long-term growth. What is important is how these two components work together. Our insurance platform provides a consistent operating foundation and financial flexibility, while our investment strategy allows us to deploy capital into emerging opportunities where we believe we can build larger ownership stakes as those businesses gain traction. As we look ahead, our focus is on continuing to execute this model in a disciplined and repetitive way, broadening our opportunity set, advancing current investments, and increasing exposure to platforms that demonstrate meaningful progress. While we are still in the early stages of this strategy, we believe the foundation we have established, combined with progress, we are beginning to see across multiple verticals position us well, to create long-term value for our shareholders. I would like now to turn the call over to Joel Markowitz, Chief Financial Officer of Reliance Global, to review the Q1 2026 financial results. Joel?